Skip to content
HowShorted

Taysha Gene Therapies, Inc. short interest in 2023

In 2023, Taysha Gene Therapies, Inc.'s disclosed short interest ran from 2.75% of shares outstanding on 13 Jan 2023 to 9.37% on 29 Dec 2023, a change of +6.62 percentage points. The year's high was 9.37% on 29 Dec 2023 and its low 1.14% on 15 Aug 2023, averaging 3.87% across 19 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.15 days on 29 Dec 2023. Full history: Taysha Gene Therapies, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Taysha Gene Therapies, Inc. in 2023

2023 in figures

Start of year
2.75% (13 Jan 2023)
End of year
9.37% (29 Dec 2023)
Change
+6.62 pp
High
9.37% (29 Dec 2023)
Low
1.14% (15 Aug 2023)
Average
3.87%
Highest days to cover
10.15 (29 Dec 2023)
SEC filings marked
8

Every report in 2023

Taysha Gene Therapies, Inc. short interest in 2023
SettlementShort interestDays to coverFilings since previous
13 Jan 20232.75%4.51
31 Jan 20233.49%4.03
15 Feb 20233.58%2.07
28 Feb 20234.27%7.47
15 Mar 20233.77%9.67
31 Mar 20233.04%3.3110-K filed, results (8-K)
14 Apr 20232.57%2.56
28 Apr 20232.72%4.59
15 May 20231.87%4.6110-Q filed, results (8-K)
31 May 20231.93%4.86
15 Jun 20232.25%7.37
30 Jun 20232.02%2.68
14 Jul 20231.77%6.02
31 Jul 20231.73%7.34
15 Aug 20231.14%1.0010-Q filed, results (8-K)
15 Nov 20237.46%3.9010-Q filed, results (8-K)
30 Nov 20238.64%7.98
15 Dec 20239.16%8.09
29 Dec 20239.37%10.15

See also: Taysha Gene Therapies, Inc.'s full history · most shorted US stocks of 2023 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.